| 2016 ESC/EAS guidelines for the management of dyslipidaemias AL Catapano, I Graham, G De Backer, O Wiklund, MJ Chapman, H Drexel, ... Polish Heart Journal (Kardiologia Polska) 74 (11), 1234-1318, 2016 | 4618 | 2016 |
| Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis F Andreotti, B Rocca, S Husted, RA Ajjan, J Ten Berg, M Cattaneo, ... European heart journal 36 (46), 3238-3249, 2015 | 249 | 2015 |
| Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of … S Halvorsen, RF Storey, B Rocca, D Sibbing, J Ten Berg, EL Grove, ... European heart journal 38 (19), 1455-1462, 2017 | 177 | 2017 |
| Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: A joint consensus document from the European heart rhythm association (EHRA) and European … GYH Lip, JP Collet, R Caterina, L Fauchier, DA Lane, TB Larsen, F Marin, ... Ep Europace 19 (11), 1757-1758, 2017 | 150 | 2017 |
| Tissue‐type plasminogen activator requires a co‐receptor to enhance NMDA receptor function AL Samson, ST Nevin, D Croucher, B Niego, PB Daniel, TW Weiss, ... Journal of neurochemistry 107 (4), 1091-1101, 2008 | 144 | 2008 |
| Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo G Rega, C Kaun, S Demyanets, S Pfaffenberger, K Rychli, ... Arteriosclerosis, thrombosis, and vascular biology 27 (7), 1587-1595, 2007 | 144 | 2007 |
| Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis B Rocca, KAA Fox, RA Ajjan, F Andreotti, C Baigent, JP Collet, EL Grove, ... European heart journal 39 (19), 1672-1686f, 2018 | 141 | 2018 |
| Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome S Demyanets, WS Speidl, I Tentzeris, R Jarai, KM Katsaros, S Farhan, ... PloS one 9 (4), e95055, 2014 | 139 | 2014 |
| Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness TW Weiss, H Arnesen, I Seljeflot Metabolism 62 (7), 1008-1013, 2013 | 132 | 2013 |
| Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue G Rega, C Kaun, TW Weiss, S Demyanets, G Zorn, SP Kastl, S Steiner, ... Circulation 111 (15), 1938-1945, 2005 | 130 | 2005 |
| Can a commercial diagnostic ultrasound device accelerate thrombolysis? An in vitro skull model S Pfaffenberger, B Devcic-Kuhar, C Kollmann, SP Kastl, C Kaun, ... Stroke 36 (1), 124-128, 2005 | 127 | 2005 |
| Positive association of the β fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to … A Gardemann, O Schwartz, W Haberbosch, N Katz, T Weiß, H Tillmanns, ... Thrombosis and haemostasis 77 (06), 1120-1126, 1997 | 120 | 1997 |
| The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-κB activation SP Kastl, WS Speidl, C Kaun, G Rega, A Assadian, TW Weiss, P Valent, ... Journal of Thrombosis and Haemostasis 4 (8), 1790-1797, 2006 | 101 | 2006 |
| IL-6 signalling in patients with acute ST-elevation myocardial infarction VN Ritschel, I Seljeflot, H Arnesen, S Halvorsen, T Weiss, J Eritsland, ... Results in immunology 4, 8-13, 2014 | 93 | 2014 |
| Why in 2016 are patients with hypertension not 100% controlled? A call to action J Redon, JJ Mourad, RE Schmieder, M Volpe, TW Weiss Journal of hypertension 34 (8), 1480-1488, 2016 | 91 | 2016 |
| Catecholamines potentiate LPS‐induced expression of MMP‐1 and MMP‐9 in human monocytes and in the human monocytic cell line U937: possible implications for peri‐operative … WS Speidl, WG Toller, C Kaun, TW Weiss, S Pfaffenberger, SP Kastl, ... The FASEB journal 18 (3), 603-605, 2004 | 90 | 2004 |
| Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1α, tumor necrosis factor-α, transforming growth factor-β and oncostatin M … K Macfelda, TW Weiss, C Kaun, JM Breuss, G Zorn, U Oberndorfer, ... Journal of molecular and cellular cardiology 34 (12), 1681-1691, 2002 | 89 | 2002 |
| Guía ESC/EAS 2016 sobre el tratamiento de las dislipemias AL Catapano, I Graham, G De Backer, O Wiklund, MJ Chapman, H Drexel, ... Revista española de cardiología 70 (2), 115. e1-115. e64, 2017 | 86* | 2017 |
| Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention M Tscharre, R Herman, M Rohla, C Hauser, S Farhan, MK Freynhofer, ... Atherosclerosis 270, 173-179, 2018 | 73 | 2018 |
| Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testing MK Freynhofer, SC Gruber, EL Grove, TW Weiss, J Wojta, K Huber Thrombosis and haemostasis 114 (09), 459-468, 2015 | 72 | 2015 |
